(Q36175858)

English

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy (English)

1 reference

Europe PubMed Central

12 August 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

object named as

Mary Kearney

12

0 references

David M. Margolis

object named as

David M Margolis

6

0 references

17

object named as

Joseph J Eron

1 reference

Europe PubMed Central

12 August 2017

Robert W Coombs

2

object named as

Robert W Coombs

1 reference

Europe PubMed Central

12 August 2017

16

object named as

John W Mellors

1 reference

Europe PubMed Central

12 August 2017

11

object named as

Ann Wiegand

1 reference

Europe PubMed Central

12 August 2017

Richard T D'Aquila

14

object named as

Richard D'Aquila

1 reference

Europe PubMed Central

12 August 2017

author name string

Rajesh T Gandhi

1

1 reference

Europe PubMed Central

12 August 2017

Ellen S Chan

3

1 reference

Europe PubMed Central

12 August 2017

Ronald J Bosch

4

1 reference

Europe PubMed Central

12 August 2017

Lu Zheng

5

1 reference

Europe PubMed Central

12 August 2017

Sarah Read

7

1 reference

Europe PubMed Central

12 August 2017

Beatrice Kallungal

8

1 reference

Europe PubMed Central

12 August 2017

Ming Chang

9

1 reference

Europe PubMed Central

12 August 2017

Erin A Goecker

10

1 reference

Europe PubMed Central

12 August 2017

Jeffrey M Jacobson

13

1 reference

Europe PubMed Central

12 August 2017

Michael M Lederman

15

1 reference

Europe PubMed Central

12 August 2017

AIDS Clinical Trials Group (ACTG) A5244 Team

18

1 reference

Europe PubMed Central

12 August 2017

language of work or name

0 references

publication date

1 March 2012

1 reference

Europe PubMed Central

12 August 2017

Journal of Acquired Immune Deficiency Syndromes

1 reference

Europe PubMed Central

12 August 2017

59

1 reference

Europe PubMed Central

12 August 2017

3

1 reference

Europe PubMed Central

12 August 2017

229-235

1 reference

Europe PubMed Central

12 August 2017

Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

The challenge of finding a cure for HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

Coamplified positive control detects inhibition of polymerase chain reactions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

1 October 2017

Short-course raltegravir intensification does not increase 2 long terminal repeat episomal HIV-1 DNA in patients on effective antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

2 July 2018

HIV cure and eradication: how will we get from the laboratory to effective clinical trials?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

23 September 2018

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

23 September 2018

Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

23 September 2018

Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423091

23 September 2018

Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22083073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22083073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/QAI.0B013E31823FD1F2

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36175858&oldid=2083353495"